Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Monica Napoleão Fortes Rego"'
Publikováno v:
Clinics, Vol 70, Iss 5, Pp 322-325 (2015)
OBJECTIVES: In Brazil, imatinib mesylate is supplied as the first-line therapy for chronic myeloid leukemia in the chronic phase through the public universal healthcare program, Sistema Único de Saúde (SUS). We studied the socio-demographic factors
Externí odkaz:
https://doaj.org/article/6992fc06362f4452867f709100e3e862
Publikováno v:
Clinics
Clinics; v. 70 n. 5 (2015); 322-325
Clinics; Vol. 70 Núm. 5 (2015); 322-325
Clinics; Vol. 70 No. 5 (2015); 322-325
Universidade de São Paulo (USP)
instacron:USP
Clinics, Vol 70, Iss 5, Pp 322-325 (2015)
Clinics, Volume: 70, Issue: 5, Pages: 322-325, Published: MAY 2015
Clinics; v. 70 n. 5 (2015); 322-325
Clinics; Vol. 70 Núm. 5 (2015); 322-325
Clinics; Vol. 70 No. 5 (2015); 322-325
Universidade de São Paulo (USP)
instacron:USP
Clinics, Vol 70, Iss 5, Pp 322-325 (2015)
Clinics, Volume: 70, Issue: 5, Pages: 322-325, Published: MAY 2015
OBJECTIVES: In Brazil, imatinib mesylate is supplied as the first-line therapy for chronic myeloid leukemia in the chronic phase through the public universal healthcare program, Sistema Único de Saúde (SUS). We studied the socio-demographic factors